Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Opinion in Cardiology|February 19, 2021
The genetics of left ventricular noncompactionDouglas Cannie, Perry Elliott
Global Cardiology Science & Practice|November 19, 2014
RAAFT-2: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillationRiyaz A Kaba, Douglas Cannie, Omar Ahmed
Open Heart|March 27, 2024
Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV blockDouglas Cannie, Kush Patel, Alexandros Protonotarios, et al.
JACC. Heart Failure|April 4, 2024
Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis: A Systematic Review and Meta-AnalysisEmanuele Monda, Athanasios Bakalakos, Douglas Cannie, et al.
Pacing and Clinical Electrophysiology : PACE|September 18, 2018
Anticoagulation and the risk of complications in ventricular tachycardia and premature ventricular complex ablationJem D Lane, Douglas Cannie, Elena Volkova, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
The contribution of <i>RBM20</i> truncating variants to human cardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
JAMA Cardiology|April 8, 2026
RBM20 Truncating Variants and Human CardiomyopathyBrendan J Floyd, Joyce N Njoroge, Vikki A Krysov, et al.
JAMA Cardiology|February 12, 2025
Arrhythmic Risk Stratification of Carriers of Filamin C Truncating Variants, Marta Gigli, Davide Stolfo, et al.
European Heart Journal|July 16, 2024
A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriersRichard T Carrick, Alessio Gasperetti, Alexandros Protonotarios, et al.
European Heart Journal|September 17, 2024
Clinical features and outcomes in carriers of pathogenic desmoplakin variantsAlessio Gasperetti, Richard T Carrick, Alexandros Protonotarios, et al.
Pageof 2